Demetrio Sharp Dimitri

Dr. Demetrio Sharp Dimitri

Cardiovascular Disease, University of Washington, Seattle, Washington, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021
Verified
Preprint
Open access
PDF file
Demetrio Sharp DimitriDemetrio Sharp Dimitri
Demetrio Sharp Dimitri
APAndrew Panakos
Andrew Panakos
CACarlos Alfonso
Carlos Alfonso
VOVicente Orozco-Sevilla
Vicente Orozco-Sevilla
We describe a patient in whom this anomaly was diagnosed during cardiac catheterization for evaluation of progressive shortness of breath and mild to moderate mitral regurgitation founded on a transthoracic echocardiogram.A 58-year-old hypertensive female was evaluated for progressive shortness of breath. Her physical examination showed a regular heart rate and rhythm, with normal heart sounds with a holosystolic systolic murmur on the 4th intercostal midclavicular line on auscultation. Electrocardiography showed normal sinus rhythm and criteria and possible left ventricular hypertrophy. Stress Echocardiogram showed with no evidence of ischemia preserved left ventricular function with an ejection fraction of 55-60%, with mild to moderate mitral regurgitation. Patient underwent a coronary catheterization for persistent shortness of breath which indicated no evidence of obstructive coronary disease, normal left ventricular function with mild to moderate mitral insufficiency. Angiography of the right coronary artery showed a very large and tortuous artery that collateralizes into the left main system and supplies the entire left coronary artery system. The left main coronary origin was from the pulmonary artery. CTA confirmed the same findings. The recommendations between cardiology and cardiothoracic surgery were to maximize medical therapy and follow up due to lack of myocardial ischemia or severe valvular disease. Currently there are no guidelines or gold standard management for patients with adult form of ALCAPA that present without ischemic burden or for patients with the disease that present asymptomatic with significant coronary collateralization.

25 July 2026 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MGMatthew Greydanus
Matthew Greydanus
Demetrio Sharp DimitriDemetrio Sharp Dimitri
Demetrio Sharp Dimitri
OKOmar A. Khan
Omar A. Khan
KKKathleen R. Khan
Kathleen R. Khan
SDScott DeRoo
Scott DeRoo
CDCreighton W. Don
Creighton W. Don

5 March 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ASAnna Subramaniam
Anna Subramaniam
Demetrio Sharp DimitriDemetrio Sharp Dimitri
Demetrio Sharp Dimitri
GMG. Burkhard Mackensen
G. Burkhard Mackensen
DEDavid Elison
David Elison
CCChristine J. Chung
Christine J. Chung
JMJames M. McCabe
James M. McCabe
A 33-year-old man with unrepaired tetralogy of Fallot, Eisenmenger syndrome, and torrential aortic regurgitation secondary to previous Streptococcus mitis endocarditis (now sterilized) presented to a local hospital with recurrent decompensated heart failure. Gated computed tomography demonstrated no calcification and an annulus area of 1328 mm2. The patient’s anatomy included an overriding aorta and a large ventriculoseptal defect, allowing for antegrade delivery of a MitraClip NT, which was successfully implanted between the right and noncoronary cusps. Final transesophogeal echocardiography showed diminished aortic regurgitation with a reduction in 3-dimensional vena contracta area from 0.37 to 0.11 cm2.

13 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Demetrio Sharp DimitriDemetrio Sharp Dimitri
Demetrio Sharp Dimitri
JPJordan M Prutkin
Jordan M Prutkin
Implantable cardioverter-defibrillators (ICDs) were historically viewed as a barrier to vigorous or competitive sport participation, based on theoretical concerns about arrhythmia induction, inappropriate shocks, device damage, and shock-related injury during activity. Contemporary registry data have reframed this paradigm, demonstrating that selected athletes with ICDs can participate in organized sport without the catastrophic outcomes once feared, although these data remain reassuring rather than definitive given selection bias and underrepresentation of high-consequence sports. This review synthesizes contemporary athlete-specific registry data and broader randomized device and programming evidence, alongside current guideline recommendations, to provide a practical framework for the care of athletes with ICDs, addressing indications, which should remain diagnosis-driven rather than sport-driven; device selection, weighing transvenous, subcutaneous, and extravascular platforms against an athlete’s pacing needs, anatomy, and sport-specific trauma risk; and exercise-informed device programming. We then present a longitudinal framework integrating clinical readiness, device readiness, sport-specific risk, emergency preparedness, shared decision-making, and reassessment after clinical or sporting changes. Special populations and priorities for future research are also discussed. Rather than a binary clearance decision, modern management of athletes with ICDs requires an individualized, longitudinally reassessed approach to risk.